Taibang Biologic Raises $300M in Post-Privatization Financing Round
Taibang Biologic Group (NASDAQ: CBPO), a plasma specialist privatized by Centurium Capital in April 2021,...
Insight, China's Pharmaceutical Industry
Fineline Insights, Pharma Clarity